Navi Medical Technologies Pty Ltd

Navi Medical Technologies is an Australian medtech company founded in 2017, specializing in innovative pediatric medical devices for critically ill newborns and children. The company addresses a critical gap in the market, as only 5% of FDA-approved devices are suitable for neonates. Navi's flagship product, the Neonav® ECG Tip Location System, uses real-time ECG surveillance technology and proprietary algorithms to enable non-invasive bedside verification of Central Vascular Access Device (CVAD) tip location in neonatal and pediatric patients. This addresses the high prevalence of CVAD malposition (>40% of umbilical venous catheters and 37% of peripherally inserted central catheters at insertion) and migration (up to 36% of UVCs and 28% of neonatal PICCs), which can lead to serious complications including cardiac arrhythmias, vessel damage, hepatic extravasation, and cardiac tamponade. The Neonav has received FDA 510(k) clearance and is supported by two patents. The company has secured $4.3 million in funding and collaborates closely with clinicians in neonatal and pediatric intensive care units to develop clinically relevant solutions.